Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
about
Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysisExpression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomesRole of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysisPositive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysisBmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy.Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.Identification and characterization of CD133+CD44+ cancer stem cells from human laryngeal squamous cell carcinoma cell lines.Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal CarcinomasIdentification and Characterization of CD133(pos) Subpopulation Cells From a Human Laryngeal Cancer Cell LinemiR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinomaThe Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma.The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
P2860
Q26796554-0CD8CE90-0CBA-45AE-88AC-B279ADE7F446Q33709741-101101A7-2A60-4DB8-B31E-64452B27732DQ36946578-7E9936DA-6E54-4254-BB94-A7E4D28C0C47Q36962860-913D42C7-A35D-40D6-8260-5C3AD3BECAAAQ37020135-3CC6ADCC-966F-4462-9AAC-A71D99723D31Q37269916-40670E6D-321C-457E-9ADB-1DDCA1BE4674Q37288364-538D7475-F61F-49ED-9D60-EA78F5CF5097Q37564476-63055511-88CA-4FEE-A7D8-4C7B320FC994Q37676008-056FA24A-5A66-4E75-9779-BCC85A1BE70AQ38727673-CED161FF-2B23-446D-A2EE-7FCA92A9F573Q38780361-CCC359CD-3566-43F0-AA62-AF8747D7ABDCQ38795514-6F8D4640-EDBD-4C24-8442-5ADC1078F5F3Q42709951-FABB4754-7BB8-43AB-80E6-DDB2BA5820D2Q47620321-465DB6A5-01A5-4469-84FE-54D6FE9D6EEFQ58769353-99C1ED2A-A724-4774-B49A-A3EC19E7CFB1
P2860
Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Colon cancer stem cell markers ...... ynchronous hepatic metastases.
@en
Colon cancer stem cell markers ...... ynchronous hepatic metastases.
@nl
type
label
Colon cancer stem cell markers ...... ynchronous hepatic metastases.
@en
Colon cancer stem cell markers ...... ynchronous hepatic metastases.
@nl
prefLabel
Colon cancer stem cell markers ...... ynchronous hepatic metastases.
@en
Colon cancer stem cell markers ...... ynchronous hepatic metastases.
@nl
P2093
P356
P1476
Colon cancer stem cell markers ...... ynchronous hepatic metastases.
@en
P2093
Chang Hyun Kim
Feifeng Jing
Hun Jin Kim
Hyeong Rok Kim
Jae Hyuk Lee
Young Jin Kim
P304
P356
10.3892/IJO.2015.2844
P577
2015-01-23T00:00:00Z